Source: International Congress 2015 – Sarcoidosis: pathogenesis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Zdenka Navrátilová (Olomouc, Czech Republic), Zdenka Navratilova, Eva Novosadova, Dagmar Smitalova, Amit Kishore, Vitezsla Kolek, Martin Petrek. Serum and bronchoalveolar exosomal miRNAs in pulmonary sarcoidosis. Eur Respir J 2015; 46: Suppl. 59, 3319

Member's Comments

No comment yet.

Related content which might interest you: The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis Source: International Congress 2014 – ILDs 5 Year: 2014 Clinical approach to pulmonary sarcoidosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Characterization of inflammation in bronchoalveolar lavage of lung transplant patients Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Utility of bronchoalveolar lavage in vasculitis patients Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Detection of exosomal miRNA in pulmonary sarcoidosis Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid Source: International Congress 2014 – Translational studies in COPD Year: 2014 Importance of early bronchoalveolar lavage in immunocompromised patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases? Source: International Congress 2015 – New insights into IIPs Year: 2015 Relationship between radiologic patterns, pulmonary function values and BALF cells in newly diagnosed sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Profile of airway mucins in bronchoalveolar lavage fluid of patients with pulmonary alveolar proteinosis Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 The effect of MUC5B promoter polymorphism on susceptibility to idiopathic interstitial pneumonias and cell profiles in bronchoalveolar Lavage fluid Source: International Congress 2015 – IPF pathogenesis Year: 2015 Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis Source: International Congress 2015 – IPF pathogenesis Year: 2015 Immunological investigation of bronchoalveolar lavage fluid of sarcoid patients Source: Eur Respir J 2002; 20: Suppl. 38, 469s Year: 2002 Levels of antimicrobial peptide LL-37 in BALF and ELF from patients with pulmonary fibrosis Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013